Risk of bleeding following double balloon enteroscopy in patients on continued antiplatelet and/or anticoagulation therapy

 

 Permissions and Reprints

Abstract

Background and study aims Anticoagulation (AC) and antiplatelet (AP) therapy may increase the risk of gastrointestinal bleeding after double balloon enteroscopy (DBE); however, limited data are currently available regarding the incidence. The aim of this study was to assess the incidence and clinical characteristics of post-DBE bleeding in patients on AC and AP therapy.

Patients and methods The medical records of patients who underwent DBE between 2009 and 2013 at Mayo Clinic, Florida, were retrospectively reviewed. Patients were divided into three groups: 1) continued AP therapy; 2) AC therapy; and 3) neither AP nor AC at the time of DBE. Follow-up data were collected at 60 days and 1 year.

Results A total of 683 patients were identified; 43 on AC, 183 on AP and 457 not on AP or AC therapy. The most common indication for DBE was obscure gastrointestinal bleeding in the groups on and not on AP (85.3 % vs 70.9 %, P < 0.0001). There was no statistical difference in post-DBE bleeding rates in patients on AP vs not on AP at 60 days (11.5 % vs 7.5 %, P = 0.12) or 1 year (19.9 % vs 15.7 %, P = 0.23). Rates of bleeding in patients on AC were 11.6 % within 60 days and 22.5 % within 1 year. Multivariate analysis reflected American Society of Anesthesiologist > 3 and indication for DBE of GI bleeding were independent risk factors for post-DBE bleeding within 1 year.

Conclusions Continued antiplatelet use at the time of DBE was not an independent risk factor for bleeding post-DBE at 60 days or 1 year of follow up.

Publication History

Received: 12 February 2021

Accepted: 25 April 2021

Article published online:
23 August 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Saygili F, Saygili SM, Oztas E. Examining the whole bowel, double balloon enteroscopy: Indications, diagnostic yield and complications. World J Gastrointest Endosc 2015; 7: 247-252
  CrossrefPubMedGoogle Scholar
• 2 Rondonotti E. Capsule retention: prevention, diagnosis and management. Ann Transl Med 2017; 5: 198
  CrossrefPubMedGoogle Scholar
• 3 Yamamoto H, Yano T, Kita H. et al. New system of double-balloon enteroscopy for diagnosis and treatment of small intestinal disorders. Gastroenterology 2003; 125: 1556 author reply 1556–1557
  CrossrefPubMedGoogle Scholar
• 4 Wang L, Xie M, Hong L. et al. The Diagnostic yields and safety of double-balloon enteroscopy in obscure gastrointestinal bleeding and incomplete small bowel obstruction: comparison between the adults and elderly. Gastroenterol Res Pract 2020; 2020: 8121625
  CrossrefPubMedGoogle Scholar
• 5 Moschler O, May A, Muller MK. et al. Complications in and performance of double-balloon enteroscopy (DBE): results from a large prospective DBE database in Germany. Endoscopy 2011; 43: 484-489
  Article in Thieme ConnectPubMedGoogle Scholar
• 6 Gerson LB, Batenic MA, Newsom SL. et al. Long-term outcomes after double-balloon enteroscopy for obscure gastrointestinal bleeding. Clin Gastroenterol Hepatol 2009; 7: 664-669
  CrossrefPubMedGoogle Scholar
• 7 Acosta RD, Abraham NS. ASGE Standards of Practice Committee. et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc 2016; 83: 3-16
  CrossrefPubMedGoogle Scholar
• 8 Bhattacharya A. Rate of bleeding on antiplatelet and anticoagulant agents in patients undergoing double balloon enteroscopy. Gastrointest Endosc 2018; 87: AB63
  CrossrefPubMedGoogle Scholar
• 9 Spencer CN. Anticoagulation status and rebleeding following double balloon enteroscopy for obscure GI bleeding. Gastrointest Endosc 2019; 89: AB339
  CrossrefPubMedGoogle Scholar
• 10 Aniwan S, Viriyautsahakul V, Luangsukrerk T. et al. Low rate of recurrent bleeding after double-balloon endoscopy-guided therapy in patients with overt obscure gastrointestinal bleeding. Surg Endosc 2021; 35: 21149-2125
  CrossrefPubMedGoogle Scholar
• 11 Samaha E, Rahmi G, Landi B. et al. Long-term outcome of patients treated with double balloon enteroscopy for small bowel vascular lesions. Am J Gastroenterol 2012; 107: 240-246
  CrossrefPubMedGoogle Scholar
• 12 Kumar A, Gandolfo F, Halwan B. Provocation of bleeding during endoscopy in patients with recurrent acute lower gastrointestinal bleeding. Gastroenterol Hepatol (N Y) 2007; 3: 570
  PubMedGoogle Scholar
• 13 Raines DL, Jex KT, Nicaud MJ. et al. Pharmacologic provocation combined with endoscopy in refractory cases of GI bleeding. Gastrointest Endosc 2017; 85: 112-120
  CrossrefPubMedGoogle Scholar
• 14 May A, Friesing-Sosnik T, Manner H. et al. Long-term outcome after argon plasma coagulation of small-bowel lesions using double-balloon enteroscopy in patients with mid-gastrointestinal bleeding. Endoscopy 2011; 43: 759-765
  Article in Thieme ConnectPubMedGoogle Scholar
• 15 Shinozaki S, Yamamoto H, Yano T. et al. Long-term outcome of patients with obscure gastrointestinal bleeding investigated by double-balloon endoscopy. Clin Gastroenterol Hepatol 2010; 8: 151-158
  CrossrefPubMedGoogle Scholar